QP-6211

N/A

Report date: 2026/01/07 16:38:40

Base Information

Drug NameQP-6211
Drug Alias NameExtended-released formulation of ropivacaineQP-6211QP6211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesNanjing Delova Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Delova Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A